Evaluation of WO2014207069 A1: Multitarget Hedgehog pathway inhibitors and uses thereof

References

• Briscoe J, Thérond PP. The mechanisms of Hedgehog signalling and its roles in development and disease. Nat Rev Mol Cell Biol. 2013;14:416–429.
   PubMed Web of Science ®Google Scholar
• Petrova R, Joyner AL. Roles for Hedgehog signaling in adult organ homeostasis and repair. Development. 2014;141:3445–3457.
   PubMed Web of Science ®Google Scholar
• Coni S, Infante P, Gulino A. Control of stem cells and cancer stem cells by Hedgehog signaling: pharmacologic clues from pathway dissection. Biochem Pharmacol. 2013;85:623–628.
   PubMed Web of Science ®Google Scholar
• Cochrane CR, Szczepny A, Watkins DN, et al. Hedgehog signaling in the maintenance of cancer stem cells. Cancers (Basel). 2015;7:1554–1585.
   PubMedGoogle Scholar
• Amakye D, Jagani Z, Dorsch M. Unraveling the therapeutic potential of the Hedgehog pathway in cancer. Nat Med. 2013;19:1410–1422.
   PubMed Web of Science ®Google Scholar
• Kieran MW. Targeted treatment for sonic hedgehog-dependent medulloblastoma. Neuro Oncol. 2014;16:1037–1047.
   PubMed Web of Science ®Google Scholar
• Ruiz Salas V, Alegre M, Garcés JR, et al. Locally advanced and metastatic basal cell carcinoma: molecular pathways, treatment options and new targeted therapies. Expert Rev Anticancer Ther. 2014;14:741–749.
   PubMed Web of Science ®Google Scholar
• Di Magno L, Coni S, Di Marcotullio L, et al. Digging a hole under Hedgehog: downstream inhibition as an emerging anticancer strategy. Biochim Biophys Acta. 2015;1856:62–72.
   PubMed Web of Science ®Google Scholar
• Xin M. Hedgehog inhibitors: a patent review (2013–present). Expert Opin Ther Pat. 2015;25:549–565.
   PubMed Web of Science ®Google Scholar
• Hadden MK. Hedgehog pathway inhibitors: a patent review (2009–present). Expert Opin Ther Pat. 2013;23:345–361.
   PubMed Web of Science ®Google Scholar
• Tremblay MR, Nesler M, Weatherhead R, et al. Recent patents for Hedgehog pathway inhibitors for the treatment of malignancy. Expert Opin Ther Pat. 2009;19:1039–1056.
   PubMed Web of Science ®Google Scholar
• Sharpe HJ, Wang W, Hannoush RN, et al. Regulation of the oncoprotein Smoothened by small molecules. Nat Chem Biol. 2015;11:246–255.
   PubMed Web of Science ®Google Scholar
• Manetti F, Taddei M, Petricci E. Structure–activity relationships and mechanism of action of small molecule smoothened modulators discovered by high-throughput screening and rational design. Top Med Chem. 2015;16:43–108.
   Google Scholar
• Hogenson T, Lauth M, Pasca Di Magliano M, et al. Back to the drawing board: re-thinking the role of GLI1 in pancreatic carcinogenesis. F1000Res. 2014;3:238.
   PubMedGoogle Scholar
• Vismodegib. U.S. Food and Drug Administration, 2012. [ cited 2015 August 25]. Available from: http://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm289571.htm
   Google Scholar
• ClinicalTrials.gov. A service of the U.S. National Institutes of Health. [ cited 2015 August 25]. Available from: https://www.clinicaltrials.gov
   Google Scholar
• Sharpe HJ, Pau G, Dijkgraaf GJ, et al. Genomic analysis of smoothened inhibitor resistance in basal cell carcinoma. Cancer Cell. 2015;27:327–341.
   PubMed Web of Science ®Google Scholar
• Atwood SX, Sarin KY, Whitson RJ, et al. Smoothened variants explain the majority of drug resistance in basal cell carcinoma. Cancer Cell. 2015;27:342–353.
   PubMed Web of Science ®Google Scholar
• Pricl S, Cortelazzi B, Dal Col V, et al. Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma. Mol Oncol. 2015;9:389–397.
   PubMed Web of Science ®Google Scholar
• Rudin CM, Hann CL, Laterra J, et al. Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N Engl J Med. 2009;361:1173–1178.
   PubMed Web of Science ®Google Scholar
• Buonamici S, Williams J, Morrissey M, et al. Interfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastoma. Sci Transl Med. 2010;2:51ra70.
   PubMed Web of Science ®Google Scholar
• http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm455862.htm
   Google Scholar
• Infante P, Alfonsi R, Botta B, et al. Targeting GLI factors to inhibit the Hedgehog pathway. Trends Pharmacol Sci. 2015;36:547–558.
   PubMed Web of Science ®Google Scholar
• Hosoya T, Arai MA, Koyano T, et al. Naturally occurring small-molecule inhibitors of Hedgehog/GLI-mediated transcription. Chem Bio Chem. 2008;9:1082–1092.
   Web of Science ®Google Scholar
• Ishibashi M, Arai AM. Search for bioactive natural products targeting cancer-related signaling pathways. J Synth Org Chem Jpn. 2009;67:1094–1104.
   Web of Science ®Google Scholar
• Arai MA. Approaches to neural stem cells and cancer cells based on natural products. Chem Pharm Bull. 2011;59:417–426.
   PubMed Web of Science ®Google Scholar
• Regl G, Neill GW, Eichberger T, et al. Human GLI2 and GLI1 are part of a positive feedback mechanism in basal cell carcinoma. Oncogene. 2002;21:5529–5539.
   PubMed Web of Science ®Google Scholar
• Shintani A, Toume K, Rifai Y, et al. A bisindole alkaloid with Hedgehog signal inhibitory activity from the Myxomycete Perichaena chrysosperma. J Nat Prod. 2010;73:1711–1713.
   PubMed Web of Science ®Google Scholar
• Arai MA, Tateno C, Hosoya T, et al. Hedgehog/GLI-mediated transcriptional inhibitors from Zizyphys cambodiana. Bioorg Med Chem. 2008;16:9420–9424.
   PubMed Web of Science ®Google Scholar
• Rifai Y, Arai MA, Koyano T, et al. Terpenoids and a flavonoid glycoside from Acacia pennata leaves as Hedgehog/GLI-mediated transcriptional inhibitors. J Nat Prod. 2010;73:995–997.
   PubMed Web of Science ®Google Scholar
• Rifai Y, Arai MA, Sadhu SK, et al. New Hedgehog/GLI signaling inhibitors from Excoecaria agallocha. Bioorg Med Chem Lett. 2011;21:718–722.
   PubMed Web of Science ®Google Scholar
• Arai MA, Tateno C, Koyano T, et al. New Hedgehog/GLI-signaling inhibitors from Adenium obesum. Org Biomol Chem. 2011;9:1133–1139.
   PubMed Web of Science ®Google Scholar
• Rifai Y, Arai MA, Koyano T, et al. Acoschimperoside P, 2ʹ-acetate: a Hedgehog signaling inhibitory constituent from Vallaris glabra. J Nat Prod. 2011;65:629–632.
   Web of Science ®Google Scholar
• Arai MA, Fujimatsu T, Uchida K, et al. Hh signaling inhibitors from Vitex negundo; naturally occurring inhibitors of the GLI1-DNA complex. Mol BioSyst. 2013;9:1012–1018.
   PubMed Web of Science ®Google Scholar
• Arai MA, Uchida K, Sadhu SK, et al. Physalin H from Solanum nigrum as an Hh signaling inhibitor blocks GLI1-DNA-complex formation. Beilstein J Org Chem. 2014;10:134–140.
   PubMed Web of Science ®Google Scholar
• Agyeman A, Jha BK, Mazumdar T, et al. Mode and specificity of binding of the small molecule GANT61 to GLI determines inhibition of GLI-DNA binding. Oncotarget. 2014;5:4492–4503.
   PubMed Web of Science ®Google Scholar
• The Regents of the University of California. Targeting Gli proteins in human cancer by small molecules. WO2014116651. 2014.
   Google Scholar
• The Regents of the University of California. Targeting Gli proteins in human cancer by small molecules. WO2007067814. 2007.
   Google Scholar
• https://projectreporter.nih.gov/project_info_description.cfm?projectnumber=1F32CA183527-01
   Google Scholar
• The Board of Trustees of the Leland Stanford Junior University. Imidazo bicyclic imminium compounds as antitumor agents. WO2013192301. 2013.
   Google Scholar
• The Board of Trustees of the Leland Stanford Junior University. Imidazo bicyclic imminium compounds as antitumor agents. US2015191489. 2015.
   Google Scholar
• Università degli Studi di Siena, Università degli Studi di Roma “La Sapienza”. Multitarget Hedgehog pathway inhibitors and uses thereof. WO2014207069. 2014.
   Google Scholar
• Manetti F, Faure H, Roudaut H, et al. Virtual screening-based discovery and mechanistic characterization of the acylthiourea MRT-10 family as Smoothened antagonists. Mol Pharmacol. 2010;78:658–665.
   PubMed Web of Science ®Google Scholar
• Pavletich NP, Pabo CO. Crystal structure of a five-finger Gli-DNA complex: new perspectives on zinc fingers. Science. 1993;261:1701–1707.
   PubMed Web of Science ®Google Scholar
• Delle Monache F, Cairo Valeira G, Sialer De Zapata D, et al 3-Aryl-4-methoxycoumarins and isoflavones from Derris glabrescens. Gazz Chim Ital. 1977;107:403–407.
   Google Scholar
• ZINC, a free database of commercially-available compounds for virtual screening. [ cited 2015 August 26]. Available from: http://zinc.docking.org
   Google Scholar
• Slusarz A, Shenouda NS, Sakla MS, et al. Common botanical compounds inhibit the Hedgehog signaling pathway in prostate cancer. Cancer Res. 2010;70:3382–3390.
   PubMed Web of Science ®Google Scholar
• Lipinski RJ, Bushman W. Identification of Hedgehog signaling inhibitors with relevant human exposure by small molecule screening. Toxicol In Vitro. 2010;24:1404–1409.
   Google Scholar
• Lauth M, Bergstrom A, Shimokawa T, et al. Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists. Proc Natl Acad Sci USA. 2007;104:8455–8460.
   PubMed Web of Science ®Google Scholar
• Infante P, Mori M, Alfonsi R, et al. Gli1/DNA interaction is a druggable target for Hedgehog-dependent tumors. Embo J. 2015;34:200–217.
   PubMed Web of Science ®Google Scholar
• Hadden MK. Targeting GLI proteins in human cancers by small molecules (WO2014116651 A1): a patent evaluation. Expert Opin Ther Patents. 2015;25:613–617.
   PubMed Web of Science ®Google Scholar